Physician

Samantha Joy Lacroce, MD

According to 2025 Medicare claims, Samantha Lacroce, MD (NPI: 1992293757) practices ophthalmology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is VISION INNOVATION CENTERS OF PENNSYLVANIA LLC (NPI: 1962046458; TIN: 84-1993683) and primary practice location at 17408-6344.

Lacroce's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 442 traditional Medicare patients, billed 1,618 HCPCS/CPT codes, and received $224,816 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 755 prescription claims across 290 beneficiaries totaling $126,165 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 13 records totaling $227. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $13,526 to $126,165. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$112K$225K2022 Medicare payment: $56,637 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $184,507 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $224,816 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022212463$56,637
20234151,362$184,507
20244421,618$224,816

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$63K$126K2018 Drug cost: $13,526 (USD; Tot_Drug_Cst)2019 Drug cost: $38,313 (USD; Tot_Drug_Cst)2020 Drug cost: $14,845 (USD; Tot_Drug_Cst)2021 Drug cost: $25,700 (USD; Tot_Drug_Cst)2022 Drug cost: $33,500 (USD; Tot_Drug_Cst)2023 Drug cost: $58,650 (USD; Tot_Drug_Cst)2024 Drug cost: $126,165 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201856167$13,526
201980414$38,313
202096200$14,845
2021102232$25,700
2022121336$33,500
2023194492$58,650
2024290755$126,165

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens169276$393
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more175175$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more264331$84
92136Measurement of corneal curvature and depth of eye242375$27
92133Imaging of optic nerve5460$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast822,610$58,407
RestasisCyclosporine341,095$18,834
CyclosporineCyclosporine391,305$13,651
BromsiteBromfenac Sodium19655$5,016
Prednisolone AcetatePrednisolone Acetate1284,498$4,425

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$227Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Samantha Joy Lacroce, MD?

Tedicare shows public-source Medicare data for Samantha Joy Lacroce, MD (NPI 1992293757), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samantha Joy Lacroce, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Samantha Joy Lacroce, MD?

Samantha Joy Lacroce, MD is linked to VISION INNOVATION CENTERS OF PENNSYLVANIA LLC (billing NPI 1962046458) in the available physician profile data.

Does Samantha Joy Lacroce, MD have Open Payments data?

Samantha Joy Lacroce, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.